Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

CompletedOBSERVATIONAL

Enrollment

142

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Malignant GliomasOligodendrogliomasAstrocytomas

Interventions

DEVICE

3 Tesla scanning

Approximately 38 brain tumor patients with IDH mutated gliomas and 50 patients with non-glioma disease will be scanned.

Trial Locations (1)

UT Southwestern Medical Center, Dallas

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT02388659 - Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas | Biotech Hunter | Biotech Hunter